Paris Biotech and Pharmaceutical Chauffeur — Institut Pasteur, Institut Curie, Sanofi and the Life Sciences Circuit

Institut Pasteur — the world's most influential biomedical research institution

Institut Pasteur (25-28 Rue du Docteur Roux 75015 — in the 15th arrondissement, on the southern edge of the 15ème, accessible via the Porte de Versailles or the Convention métro station) :

**The history:** The Institut Pasteur was founded in 1887 by public subscription at the initiative of Louis Pasteur (1822-1895) — the chemist and microbiologist who developed the germ theory of disease, discovered the vaccine against rabies (1885 — the first human patient was the 9-year-old Joseph Meister, bitten by a rabid dog in Alsace), and invented the process of pasteurisation. Pasteur's original laboratory and his apartment (maintained exactly as they were at his death in 1895, including his personal microscopes and the correspondence with Robert Koch) are preserved within the Institut campus as a museum. Pasteur is buried in the crypt beneath the chapel on the campus.

**The research portfolio:** The Institut Pasteur conducts research in approximately 130 research units, employing 2,800 researchers from 100 countries. The key research areas include: infectious diseases (HIV — the Institut Pasteur team of Luc Montagnier and Françoise Barré-Sinoussi isolated the AIDS virus in 1983, winning the Nobel Prize in Physiology or Medicine in 2008), emerging infectious diseases (SARS-CoV-2 — the Institut Pasteur was the first European institution to isolate and culture the COVID-19 virus in January 2020), neuroscience, cancer biology, and global health. Ten Nobel Prize winners have been associated with the Institut Pasteur, including Élie Metchnikoff (innate immunity, 1908), Jules Bordet (serology, 1919), and the HIV research team (2008).

**The international network:** The Institut Pasteur International Network comprises 33 institutes in 25 countries — in Africa, Asia, the Middle East, and the Americas — making it the largest network of biomedical research institutes under a single governance structure. The network institutes serve as sentinel surveillance stations for emerging infectious diseases.

**FFGR access:** The Institut Pasteur campus is not generally open to the public — access to the research facilities requires institutional accreditation. FFGR can coordinate the logistics for visiting researchers, industry partners, and delegation visits by arrangement with the Institut Pasteur international relations department.

Institut Curie — the cancer research centre founded by Marie Curie

Institut Curie (26 Rue d'Ulm 75005 — in the 5th arrondissement, in the Quartier Latin, adjacent to the École Normale Supérieure and 200 metres from the Panthéon) :

**The history:** The Institut Curie was founded by Marie Sklodowska-Curie (1867-1934) — the only person to have won Nobel Prizes in two different scientific disciplines (Physics, 1903, shared with Pierre Curie and Henri Becquerel, for the discovery of radioactivity; Chemistry, 1911, for the isolation of radium and polonium) — as the Institut du Radium in 1909. The institute was renamed the Institut Curie in 1932 and combined with the Curie hospital in 1978 to create the integrated cancer research and treatment centre that exists today.

**The research and clinical activities:** The Institut Curie is simultaneously a research centre (approximately 1,200 researchers in 87 research teams) and a hospital (approximately 12,000 new cancer patients per year, with particular specialisations in breast cancer, paediatric oncology, and rare tumours). The research-clinical integration model — where laboratory findings from the research units are directly translated into clinical protocols at the hospital — is considered the most advanced in France and among the most advanced in Europe.

**The Nobel Prize legacy:** In addition to Marie Curie's two Nobel Prizes, the Institut Curie is associated with Frédéric Joliot-Curie and Irène Joliot-Curie (Marie Curie's daughter and son-in-law), who received the Nobel Prize in Chemistry in 1935 for the synthesis of new radioactive elements. The Curie family thus accounts for five Nobel Prizes across three generations — a unique distinction in the history of science.

**The Musée Curie:** The museum on the Institut Curie campus (1 Rue Pierre et Marie Curie 75005) preserves Marie Curie's personal laboratory, her notebooks (still radioactive after 130 years — researchers consult them in lead-lined gloves), and the original apparatus used to isolate radium. The museum is open to the public by appointment.

Sanofi — France's global pharmaceutical champion

Sanofi (54 Rue La Boétie 75008 — global headquarters in the 8th arrondissement, between the Champs-Élysées and the Boulevard Haussmann; principal research campus at 1 Avenue Pierre Brossolette 91385 Chilly-Mazarin, 20 kilometres south of Paris) :

**The company:** Sanofi is the largest pharmaceutical company in France and one of the five largest in the world — with 2023 revenues of €44.3 billion, an R&D budget of €9.4 billion (21% of revenues, one of the highest R&D ratios in the industry), approximately 91,000 employees in 60 countries, and a portfolio that includes Dupixent (dupilumab — the anti-inflammatory biologic that became the fastest-growing pharmaceutical product in history, reaching €11 billion in annual sales in 2023), Toujeo (insulin glargine), and the Vaccines division (SANOFI Pasteur — one of the largest vaccine producers globally, responsible for approximately 20% of all doses of flu vaccine administered globally each year).

**The corporate history:** Sanofi was created through a series of mergers and acquisitions: the original Sanofi was founded in 1973 as a subsidiary of Elf Aquitaine; it merged with Synthélabo (itself a product of multiple mergers including Roussel-UCLAF) in 1999 to form Sanofi-Synthélabo; this merged with Aventis (the product of the Hoechst-Marion Merrell Dow-Roussel merger) in 2004 to form Sanofi-Aventis; the company was renamed simply Sanofi in 2011 under CEO Chris Viehbacher.

**Research partnerships:** Sanofi has research partnerships with the Institut Pasteur (infectious diseases, mRNA vaccine technology), Institut Curie (oncology), and with major academic medical centres including APHP (Assistance Publique-Hôpitaux de Paris — the largest hospital system in Europe, with 38 hospital groups and approximately 100,000 employees).

The Paris-Saclay biotech cluster

Paris-Saclay (Plateau de Saclay, 91 — approximately 25 kilometres southwest of Paris, accessible via the N118 motorway or RER B to Saint-Rémy-lès-Chevreuse) :

**The cluster:** The Paris-Saclay campus represents the largest concentration of research and higher education in a single location in France and one of the largest in Europe — with the Université Paris-Saclay (ranked 1st in France and 14th globally in the 2024 QS World University Rankings in the natural sciences), the École Polytechnique, CentraleSupélec, and approximately 80,000 students and researchers on a 7,700-hectare plateau.

**The biotech ecosystem:** The life sciences component of Paris-Saclay includes the Génopole (Europe's first biotech cluster, founded 1998, located at Évry-Courcouronnes 30km south of Paris — 90+ biotech companies including Sanofi Genzyme, Servier, and leading gene therapy startups), the Université Paris-Saclay faculty of medicine and pharmacy, and the research institutes of CEA (Commissariat à l'Énergie Atomique) and CNRS that focus on structural biology, genomics, and neuroscience.

**Ipsen:** One of France's most internationally successful mid-cap pharmaceutical companies, Ipsen (65 Quai Georges Gorse 92100 Boulogne-Billancourt, listed on Euronext Paris — 2023 revenues of €4.0 billion) is headquartered in Boulogne-Billancourt and specialises in oncology, rare diseases, and neuroscience. The Dysport brand (botulinum toxin — the medical precursor of Botox) was developed and is still produced by Ipsen.

**Servier:** Servier (22 Rue Garnier 92200 Neuilly-sur-Seine — the only remaining large independent French pharmaceutical company, founded by Jacques Servier in 1954, 2023 revenues approximately €5.5 billion) is notable for remaining 100% private — with a governance structure that places 100% of the shares in a foundation — ensuring that the company cannot be acquired by a foreign group. Research is headquartered at the Centre de Recherche Servier at Gif-sur-Yvette, adjacent to the Paris-Saclay campus.

APHP and the hospital circuit

Assistance Publique-Hôpitaux de Paris (AP-HP — 3 Avenue Victoria 75004 — central headquarters in the 4th arrondissement) :

**The institution:** AP-HP is the largest hospital system in Europe — 38 hospital groups, approximately 100,000 employees, 22,000 beds, 8 million outpatient visits per year. The AP-HP group includes some of the most historically and clinically significant hospitals in the world: the Hôtel-Dieu (founded 651 AD on the Île de la Cité, the oldest functioning hospital in the world), the Hôpital Lariboisière (1854, the model for Haussmann-era hospital architecture), the Pitié-Salpêtrière (1656 — where Jean-Martin Charcot developed modern neurology and studied hysteria with the young Sigmund Freud), and the Hôpital Necker (1778 — where Necker-Enfants Malades remains the leading paediatric hospital in France and one of the three leading in Europe).

**Hôpital Américain de Paris:** For international UHNW clients, the Hôpital Américain de Paris (63 Boulevard Victor Hugo 92200 Neuilly-sur-Seine — in Neuilly, adjacent to the 16th arrondissement, accessible in 15 minutes from the Triangle d'Or) is the preferred medical facility — accredited by the Joint Commission International, with English-speaking staff, a VIP wing, and relationships with the principal specialists of APHP. FFGR provides the medical transport for clients requiring clinical visits, surgical procedures, or emergency hospital access.

Booking the Paris life sciences circuit

FFGR structures the Paris life sciences transport service for several profiles of client :

**The biotech executive circuit:** CDG airport → hotel (15-minute transfer with briefing on Paris traffic patterns) → Sanofi headquarters (54 Rue La Boétie) → lunch in the 8ème or at a three-star in the Triangle d'Or → Institut Pasteur campus (25 Rue du Docteur Roux) → Paris-Saclay (N118, 35 minutes in light traffic) → CDG or hotel. Full-day executive circuits can cover 4-6 institutional addresses.

**The investor delegation:** for private equity and venture capital delegations visiting Paris biotech portfolio companies or conducting institutional due diligence (Genopole visits, Paris-Saclay lab tours, APHP partnership meetings), FFGR provides the vehicle management for multi-car convoys and can coordinate with security teams for UHNW principal protection.

**Medical tourism and clinical access:** for UHNW clients seeking specialist consultations at the Institut Curie, the APHP specialist centres, or the Hôpital Américain, FFGR provides the discrete medical transport — from hotel to clinic and back, with extended waiting capacity for appointments of uncertain duration. The FFGR team has established relationships with the medical transport coordination teams at the principal Parisian hospitals.

Contact us at reservation@ffgrparis.com or WhatsApp +33 7 43 46 14 91.